In this article, we will discuss Enasidenib and Differentiation Syndrome. So, let’s get started.
Advise patients on the risks of developing differentiation syndrome as early as 10 days and during the first 5 months on treatment. Ask patients to immediately report any symptoms suggestive of differentiation syndrome, such as fever, cough or difficulty breathing, bone pain, rapid weight gain or
swelling of their arms or legs, to their healthcare provider for further evaluation